0001654954-21-000231.txt : 20210107 0001654954-21-000231.hdr.sgml : 20210107 20210107155540 ACCESSION NUMBER: 0001654954-21-000231 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210107 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210107 DATE AS OF CHANGE: 20210107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TPT GLOBAL TECH, INC. CENTRAL INDEX KEY: 0001661039 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATION SERVICES, NEC [4899] IRS NUMBER: 813903357 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-222094 FILM NUMBER: 21514171 BUSINESS ADDRESS: STREET 1: 501 W. BROADWAY, SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92101 BUSINESS PHONE: (619) 301-4200 MAIL ADDRESS: STREET 1: 501 W. BROADWAY, SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92101 8-K 1 tptw_8k.htm CURRENT REPORT tptw_8k
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report:  January 7, 2021
  
TPT Global Tech, Inc.
(Exact name of registrant as specified in its charter)
  
Florida
 
333-222094
 
81-3903357
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification Number)
  
501 West Broadway, Suite 800, San Diego, CA 92101
(Address of Principal Executive Offices) (Zip Code)
 
(619)301-4200
Registrant's telephone number, including area code
 
                                                                                                            
(Former name or former address, if changed since last report)
 
            Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
[    ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[    ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[    ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[    ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act: None 
 
Title of each Class
Trading Symbol
Name of each exchange on which registered
N/A
N/A
N/A
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
 
Emerging Growth Company ☒ 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 
 
 
Item 7.01 Regulation FD Disclosure.
 
Press Release
 
The information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in such filing.
 
On January 7, 2021, the Company issued a press release entitled “TPT Global Tech's (OTCQB:TPTW) Innovaqor (OTC:INOQ) Completes Agreement to Acquire the Software and Genetic Diagnostics Interpretation Divisions of Rennova Health Inc.” A copy of the press release is attached hereto as Exhibit 99.1.
 
Item 9.01 Exhibits
 
The following exhibits are filed with this report on Form 8-K.
 
Exhibit Number
 
Exhibit
 
Press Release, dated January 7, 2021
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
 
TPT GLOBAL TECH, INC.
 
 
 
 
 

By:  
/s/ Stephen J. Thomas
 

 
Stephen J. Thomas 
 

 
Title: Chief Executive Officer 
 

 
   
 
 
 
 Date: January 7, 2021
 
 
 
 
 
 

 
 EX-99.1 2 tptw_ex991.htm PRESS RELEASE tptw_ex991
  Exhibit 99.1
 
TPT Global Tech's (OTCQB:TPTW) Innovaqor (OTC:INOQ) Completes Agreement to Acquire the Software and Genetic Diagnostics Interpretation Divisions of Rennova Health Inc.
 
SAN DIEGO, CA / ACCESSWIRE / January 7, 2021 / TPT Global Tech, Inc. www.tptglobaltech.com ("TPTW or the Company") (OTCQB:TPTW) announced today that it has completed its purchase agreement with Rennova Health, Inc. ("Rennova"), an owner and operator of rural hospitals in Tennessee and InnovaQor, Inc. (OTC:INOQ) (InnovaQor), a CO based public company and a subsidiary of TPTW, to merge Rennova's software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into InnovaQor. After closing, these entities will operate as wholly-owned subsidiaries of InnovaQor which will then be controlled by Rennova. Closing is subject to several customary conditions for a transaction of this nature and is intended to happen on or before January 31. 2020.
 
InnovaQor has previously completed a license agreement giving it certain rights to assets and technology from TPT Global Tech, Inc's proprietary live streaming communication technology. As part of the License agreement, InnovaQor and TPT have agreed on a development project to create a next-generation telehealth type platform. It is intended to combine the TPT and Rennova assets and technology into a smartphone and computer-accessible healthcare platform to facilitate a patient's immediate access to healthcare and their local hospital or doctors office, for an initial consultation, scheduling of appointments and follow on care, and other added-value services that may be one-off or recurring.
 
Rennova has agreed to complete the necessary steps and SEC filings with the intent to facilitate TPT shareholders receiving approximately 2,500,000 shares in InnovaQor, and Rennova's shareholders receiving approximately $5M of preferred shares which can be converted to common shares. As described in the agreement, TPT will retain direct ownership of an additional 2,500,000 shares and Rennova will retain ownership of an additional $17.5M of preferred shares with certain conversion rights and restrictions, making it the controlling entity in InnovaQor. An additional 1,000,000 shares in InnovaQor will be allocated to TPT or its assignees as an incentive to assist in product development.
 
"We are delighted to complete this transaction and firmly believe it creates opportunity and value for our shareholders from TPT owned technology", said Stephen Thomas, CEO of TPT Global Tech. "Our live streaming communication technology is already in use in our core business and we look forward to this technology being used under license by InnovaQor to develop a platform to create needed and exciting solutions for the medical sector. These solutions will include a telehealth like platform into which additional services and solutions for hospitals, physicians and patients can be integrated"
 
 
 
 
About TPT Global Tech
 
TPT Global Tech Inc. (TPTW) based in San Diego, California, is a technology-based company with divisions providing telecommunications, medical technology and product distribution, media content for domestic and international syndication as well as technology solutions. TPT Global Tech offers Software as a Service (SaaS), Technology Platform as a Service (PAAS), Cloud-based Unified Communication as a Service (UCaaS). It offers carrier-grade performance and support for businesses over its private IP MPLS fiber and wireless network in the United States. TPT's cloud-based UCaaS services allow businesses of any size to enjoy all the latest voice, data, media, and collaboration features in today's global technology markets. TPT Global Tech also operates as a Master Distributor for Nationwide Mobile Virtual Network Operators (MVNO) and Independent Sales Organization (ISO) as a Master Distributor for Pre-Paid Cell phone services, Mobile phones Cell phone Accessories and Global Roaming Cell phones. TPT's MedTech division is focused on implementing rapid COVID testing systems and software for verifying COVID testing and vaccinations. These apps will be used for entry to airlines, sporting events, and businesses.
 
Forward-Looking Statements
 
This press release contains "forward-looking statements" within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings, and pursuit of new markets are forward-looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases, the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.
 
CONTACT:
 
Frank Benedetto
619-915-9422
 
SOURCE: TPT Global Tech, Inc.